Differential expression of translation-associated genes in benign and malignant human breast tumours
1992

Gene Expression Differences in Breast Tumors

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): S.M. Adams, M.G.F. Sharpl, R.A. Walker, W.J. Brammarl, J.M. Varley

Primary Institution: University of Leicester

Hypothesis

Are there differences in the expression of translation-associated genes between benign and malignant breast tumors?

Conclusion

The study found that certain genes associated with translation are expressed at higher levels in benign breast tumors compared to malignant ones.

Supporting Evidence

  • Fibroadenomas showed significantly higher expression levels of EF-la and HUBCEP80 compared to carcinomas.
  • Previous studies indicated that other translation-associated proteins also have higher expression in benign tumors.

Takeaway

This study looked at breast tumors and found that benign tumors have more of certain proteins than cancerous ones, which might help doctors understand how to treat breast cancer better.

Methodology

The study involved differential screening of cDNA libraries from breast tumor samples to identify gene expression differences.

Limitations

The study did not determine the relative levels of expression of EF-la mRNAs in carcinomas and fibroadenomas by in situ hybridization due to quantification difficulties.

Participant Demographics

The study included human breast tumor samples from 17 carcinomas and 17 fibroadenomas.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication